MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s12094-022-02838-3

Медицинская библиотека · Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022

Impact of cranial stereotactic radiotherapy associated with immunotherapy with nivolumab and ipilimumab on overall survival in patients with melanoma brain metastases: a real-world evidence.

de Castro Douglas Guedes, Teixeira Carlos Henrique Andrade, Gondim Guilherme Rocha Melo, Aguilar Patrícia Bailão, Costa Marcos André de Sá Barreto, Jorge Thiago William Carnier, Morais Hanriot Rodrigo de

СтатьяПеревод пока не подготовлен

Аннотация

PURPOSE: To evaluate the impact of cranial stereotactic radiotherapy (SRT) on overall survival (OS) of melanoma brain metastases (MBM) patients treated with combined nivolumab and ipilimumab (CNI) in a contemporary and real-world setting.

METHODS/PATIENTS: The study was performed by using TriNetX, a global health network dataset of electronic medical records from patients in 49 healthcare organizations. We queried for patients with specific terms between January 2016 and December 2020 and run a propensity score matching (PSM) analysis. OS was estimated by Kaplan-Meier and log-rank test was applied.

RESULTS

After initial query and PSM, 114 patients were selected in each cohort. Median OS was 327 days in CNI and not reached in the CNI + SRT cohort, with OS probability of 54.4 and 40.9%, respectively (log-rank P = .0057). CNI + SRT was associated with significantly decreased mortality (HR, 0.57; 95% CI 0.377-0.853; proportionality P = .0034).

CONCLUSIONS

This real-world analysis showed that CNI + SRT led to an improvement in OS compared to CNI.

Для цитирования: de Castro Douglas Guedes, Teixeira Carlos Henrique Andrade, Gondim Guilherme Rocha Melo, Aguilar Patrícia Bailão, Costa Marcos André de Sá Barreto, Jorge Thiago William Carnier, Morais Hanriot Rodrigo de. Impact of cranial stereotactic radiotherapy associated with immunotherapy with nivolumab and ipilimumab on overall survival in patients with melanoma brain metastases: a real-world evidence.. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2022. DOI: 10.1007/s12094-022-02838-3.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.